ROSUVASTATIN MAY LOWER VASCULAR DEMENTIA RISK
| dc.contributor.author | Bositkhonov Akmalkhon Nosirkhon ugli | |
| dc.contributor.author | Jumaniyazov Bexzod Kadirberganovich | |
| dc.date.accessioned | 2025-12-31T15:38:32Z | |
| dc.date.issued | 2024-01-30 | |
| dc.description.abstract | Cognitive impairment is common in older people with ischemic heart disease. The first reason is dyslipidemia-distributed atherosclerosis, and the second reason is impaired pumping function of the heart in heart failure. In dyslipidemia, the amount of antiatherogenic lipids increases. The most effective drug in this case is rozurvastatin. Rosurvastatin reduces the size of atherosclerotic plaques not only in the heart, but also in the brain, improves blood circulation and blood supply to cells, therefore it can reduce the risk of dementia in the elderly | |
| dc.format | application/pdf | |
| dc.identifier.uri | https://scholarexpress.net/index.php/wbph/article/view/3728 | |
| dc.identifier.uri | https://asianeducationindex.com/handle/123456789/49605 | |
| dc.language.iso | eng | |
| dc.publisher | Scholar Express Journals | |
| dc.relation | https://scholarexpress.net/index.php/wbph/article/view/3728/3174 | |
| dc.rights | https://creativecommons.org/licenses/by-nc-nd/4.0 | |
| dc.source | World Bulletin of Public Health; Vol. 30 (2024): WBPH; 124-125 | |
| dc.source | 2749-3644 | |
| dc.subject | Rosurvastatin | |
| dc.subject | ischemic heart disease | |
| dc.subject | Cognitive impairment | |
| dc.title | ROSUVASTATIN MAY LOWER VASCULAR DEMENTIA RISK | |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
| dc.type | Peer-reviewed Article |
item.page.files
item.page.filesection.original.bundle
pagination.showing.detail
loading.default
- item.page.filesection.name
- ugli_2024_rosuvastatin_may_lower_vascular_dementia.pdf
- item.page.filesection.size
- 161.85 KB
- item.page.filesection.format
- Adobe Portable Document Format